Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OxMet Technologies is a materials science company that utilizes its proprietary Alloy by Design (ABD) computational platform to develop high-performance alloys for demanding medical and industrial applications. Spun out from the University of Oxford, the company specializes in creating biocompatible alloys, such as high-strength titanium and nickel-free stainless steels, specifically optimized for additive manufacturing (3D printing) in the orthopedic and dental sectors. Their technology enables the rapid discovery of alloys with tailored mechanical properties and improved osseointegration characteristics for surgical implants. In July 2023, OxMet was acquired by Sandvik, integrating its advanced metallurgy software and proprietary alloy powders into Sandvik's additive manufacturing business unit.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OxMet Technologies.